• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善与年龄相关的黄斑变性的功能:一项随机临床试验的设计和方法。

Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.

机构信息

Departments of Psychiatry and Neurology, Jefferson Medical College, Jefferson Hospital for Neuroscience, 900 Walnut Street, 4th Floor, Philadelphia, PA 19107, United States.

出版信息

Contemp Clin Trials. 2011 Mar;32(2):196-203. doi: 10.1016/j.cct.2010.10.008. Epub 2010 Oct 23.

DOI:10.1016/j.cct.2010.10.008
PMID:20974293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3034775/
Abstract

Age-Related Macular Degeneration (AMD) is the leading cause of severe vision loss in older adults and impairs the ability to read, drive, and live independently and increases the risk for depression, falls, and earlier mortality. Although new medical treatments have improved AMD's prognosis, vision-related disability remains a major public health problem. Improving Function in AMD (IF-AMD) is a two-group randomized, parallel design, controlled clinical trial that compares the efficacy of Problem-Solving Therapy (PST) with Supportive Therapy (ST) (an attention control treatment) to improve vision function in 240 patients with AMD. PST and ST therapists deliver 6 one-hour respective treatment sessions to subjects in their homes over 2 months. Outcomes are assessed masked to treatment assignment at 3 months (main trial endpoint) and 6 months (maintenance effects). The primary outcome is targeted vision function (TVF), which refers to specific vision-dependent functional goals that subjects highly value but find difficult to achieve. TVF is an innovative outcome measure in that it is targeted and tailored to individual subjects yet is measured in a standardized way. This paper describes the research methods, theoretical and clinical aspects of the study treatments, and the measures used to evaluate functional and psychiatric outcomes in this population.

摘要

年龄相关性黄斑变性(AMD)是导致老年人严重视力丧失的主要原因,它会损害阅读、驾驶和独立生活的能力,增加抑郁、跌倒和早亡的风险。尽管新的医疗方法改善了 AMD 的预后,但与视力相关的残疾仍然是一个主要的公共卫生问题。改善 AMD 患者的功能(IF-AMD)是一项两臂随机、平行设计、对照临床试验,比较了问题解决疗法(PST)与支持性疗法(ST)(一种注意力对照疗法)在 240 名 AMD 患者中改善视力功能的疗效。PST 和 ST 治疗师在 2 个月内为患者的家庭提供 6 次 1 小时的各自治疗课程。在 3 个月(主要试验终点)和 6 个月(维持效果)时,对治疗分配进行盲法评估结局。主要结局是目标视力功能(TVF),它是指患者高度重视但难以实现的特定视力依赖性功能目标。TVF 是一种创新的结局测量方法,因为它是针对个体患者的目标和量身定制的,但以标准化的方式进行测量。本文介绍了研究方法、研究治疗的理论和临床方面,以及用于评估该人群功能和精神结局的措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d56/3034775/70b2dfbe349f/nihms248267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d56/3034775/70b2dfbe349f/nihms248267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d56/3034775/70b2dfbe349f/nihms248267f1.jpg

相似文献

1
Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.改善与年龄相关的黄斑变性的功能:一项随机临床试验的设计和方法。
Contemp Clin Trials. 2011 Mar;32(2):196-203. doi: 10.1016/j.cct.2010.10.008. Epub 2010 Oct 23.
2
Improving function in age-related macular degeneration: a randomized clinical trial.改善年龄相关性黄斑变性的功能:一项随机临床试验。
Ophthalmology. 2013 Aug;120(8):1649-55. doi: 10.1016/j.ophtha.2013.01.022. Epub 2013 May 1.
3
Preventing depression in age-related macular degeneration.预防年龄相关性黄斑变性中的抑郁症
Arch Gen Psychiatry. 2007 Aug;64(8):886-92. doi: 10.1001/archpsyc.64.8.886.
4
Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial.年龄相关性黄斑变性低视力抑郁预防试验:一项随机临床试验。
Ophthalmology. 2014 Nov;121(11):2204-11. doi: 10.1016/j.ophtha.2014.05.002. Epub 2014 Jul 9.
5
Preventing late-life depression in age-related macular degeneration.预防年龄相关性黄斑变性中的老年期抑郁症。
Am J Geriatr Psychiatry. 2008 Jun;16(6):454-9. doi: 10.1097/JGP.0b013e31816b7342.
6
Self-management of age-related macular degeneration and quality of life: a randomized controlled trial.年龄相关性黄斑变性的自我管理与生活质量:一项随机对照试验
Arch Ophthalmol. 2002 Nov;120(11):1477-83. doi: 10.1001/archopht.120.11.1477.
7
Dissatisfaction with performance of valued activities predicts depression in age-related macular degeneration.对有价值活动表现的不满预示着年龄相关性黄斑变性患者会出现抑郁。
Int J Geriatr Psychiatry. 2007 Aug;22(8):789-93. doi: 10.1002/gps.1742.
8
Implementing a multi-modal support service model for the family caregivers of persons with age-related macular degeneration: a study protocol for a randomised controlled trial.为年龄相关性黄斑变性患者的家属实施多模式支持服务模式:一项随机对照试验研究方案。
BMJ Open. 2017 Aug 4;7(8):e018204. doi: 10.1136/bmjopen-2017-018204.
9
Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration.年龄相关性黄斑变性低视力抑郁症预防试验的功能结局
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1514-1520. doi: 10.1167/iovs.16-20001.
10
The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.黄斑变性与衰老研究:一项针对黄斑变性患者的社会心理干预随机试验的设计与研究方案
Contemp Clin Trials. 2015 May;42:68-77. doi: 10.1016/j.cct.2015.03.007. Epub 2015 Mar 24.

引用本文的文献

1
Low vision rehabilitation for better quality of life in visually impaired adults.低视力康复改善视力受损成年人的生活质量。
Cochrane Database Syst Rev. 2020 Jan 27;1(1):CD006543. doi: 10.1002/14651858.CD006543.pub2.
2
Longitudinal observation, evaluation and interpretation of coping with mental (emotional) health in low vision rehabilitation using the Dutch ICF Activity Inventory.使用荷兰版国际功能、残疾和健康分类活动量表对低视力康复中应对心理健康(情绪健康)的情况进行纵向观察、评估和解读。
Health Qual Life Outcomes. 2014 Dec 24;12:182. doi: 10.1186/s12955-014-0182-4.
3
Dual sensory loss: development of a dual sensory loss protocol and design of a randomized controlled trial.

本文引用的文献

1
Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration.年龄相关性黄斑变性抗血管内皮生长因子治疗后仍出现抑郁症状
Arch Ophthalmol. 2010 Apr;128(4):506-8. doi: 10.1001/archophthalmol.2010.24.
2
Assuring that double-blind is blind.确保双盲试验真正做到盲法。
Am J Psychiatry. 2010 Mar;167(3):250-2. doi: 10.1176/appi.ajp.2009.09060820.
3
Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.预测到2050年与年龄相关的黄斑变性:新疗法的潜在影响。
双重感觉损失:双重感觉损失协议的制定和随机对照试验的设计。
BMC Geriatr. 2013 Aug 13;13:84. doi: 10.1186/1471-2318-13-84.
4
Stepped-care to prevent depression and anxiety in visually impaired older adults--design of a randomised controlled trial.阶梯式护理预防视障老年人抑郁和焦虑——一项随机对照试验的设计。
BMC Psychiatry. 2013 Aug 9;13:209. doi: 10.1186/1471-244X-13-209.
Arch Ophthalmol. 2009 Apr;127(4):533-40. doi: 10.1001/archophthalmol.2009.58.
4
Risk of admission to a nursing home among older people with visual impairment in Great Britain.英国视力受损老年人入住养老院的风险。
Arch Ophthalmol. 2008 Oct;126(10):1428-33. doi: 10.1001/archopht.126.10.1428.
5
Older women with age-related macular degeneration have a greater risk of falls: a physiological profile assessment study.年龄相关性黄斑变性老年女性跌倒风险更高:一项生理特征评估研究。
J Am Geriatr Soc. 2008 May;56(5):800-7. doi: 10.1111/j.1532-5415.2008.01666.x. Epub 2008 Mar 20.
6
Burden of illness of neovascular age-related macular degeneration in Canada.加拿大新生血管性年龄相关性黄斑变性的疾病负担。
Can J Ophthalmol. 2007 Dec;42(6):836-43. doi: 10.3129/i07-153.
7
The Activity Inventory: an adaptive visual function questionnaire.活动量表:一种适应性视觉功能问卷。
Optom Vis Sci. 2007 Aug;84(8):763-74. doi: 10.1097/OPX.0b013e3181339efd.
8
An interval-scaled scoring algorithm for visual function questionnaires.一种用于视觉功能问卷的区间尺度评分算法。
Optom Vis Sci. 2007 Aug;84(8):E690-705. doi: 10.1097/OPX.0b013e31812f5f35.
9
Preventing depression in age-related macular degeneration.预防年龄相关性黄斑变性中的抑郁症
Arch Gen Psychiatry. 2007 Aug;64(8):886-92. doi: 10.1001/archpsyc.64.8.886.
10
Problem solving therapies for depression: a meta-analysis.抑郁症的问题解决疗法:一项荟萃分析。
Eur Psychiatry. 2007 Jan;22(1):9-15. doi: 10.1016/j.eurpsy.2006.11.001. Epub 2006 Dec 27.